William Clayton is likely known to most members of The Church of Jesus Christ of Latter-day Saints as the author of the ...

Brian Manning, who previously worked at health tech companies like Bamboo Health and Zocdoc, replaces the AI company’s ...

Both colors are reduced.

Mikel Gurrea's "Sants," with "The Beloved" star Vicky Luengo, joins in San Sebastian's main competition alongside Berto ...

Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...

Reader, it’s a note-taking tool too. While the recent Colorsoft range of Kindles with colour screens featured a base model, a ...

The task of taking parts of the oldest book copy of The Odyssey to the US for the stars of Christopher Nolan's cinematic ...

Ambient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a highly ...

Scribe Therapeutics on Monday said it plans to sell 7.15 million shares at between $13 and $15 apiece in its initial public offering. At the $14 midpoint of that price range, the Alameda, Calif., ...

Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, is seeking to raise as much as $107.2 million in a US initial public offering.

The newest TBBT spin-off "Stuart Fails to Save the Universe" could go further in establishing its sci-fi rules, but overall ...

Why this 2-year-old San Francisco company filed for an IPO © 2026 American City Business Journals. All rights reserved. Use ...